Hilda Sánchez-Vidal

Hilda Sánchez-Vidal


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
OVOlynka Vega-Vega
Olynka Vega-Vega
JFJosé Carlos Páez Franco
José Carlos Páez Franco
MMMiguel Ángel Martínez-Rojas
Miguel Ángel Martínez-Rojas
IGIsaac González-Soria
Isaac González-Soria
JOJuan Antonio Ortega-Trejo
Juan Antonio Ortega-Trejo
OVOlynka Vega Vega
Olynka Vega Vega
Background/Objectives: COVID-19 is a systemic viral infection that may lead to serious complications including acute kidney injury that requires kidney replacement therapy. The primary aim of this study was to evaluate urinary SerpinA3 (uSerpinA3) excretion as a biomarker of kidney recovery at 90 days, and the mortality in patients with critical COVID-19 and AKI requiring kidney replacement therapy (KRT). Methods: The study included patients with critical COVID-19 on invasive mechanical ventilation (IMV) requiring KRT. Blood and urine samples were obtained when KRT was initiated (day zero), and thereafter on days 1, 3, 7, and 14 post-replacement. uSerpinA3, kidney injury molecule-1 (uKIM-1), and neutrophil gelatinase-associated lipocalin (uNGAL) were measured in urine, and interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-α) in peripheral blood. In addition, metabolomics in sample days zero and 3, and in the survivors on sample day 90 was performed by employing gas chromatography coupled with mass spectrometry. Results: A total of 60 patients were recruited, of whom 29 (48%) survived hospitalization and recovered kidney function by day 90. In the survivors, 79% presented complete recovery (CRR) and the remaining (21%) recovered partially (PRR). In terms of uSerpinA3, levels on days 7 and 14 predicted CRR, with AUC values of 0.68 (p = 0.041) and 0.71 (p = 0.030), respectively, as well as mortality, with AUC values of 0.75 (p = 0.007) and 0.76 (p = 0.015), respectively. Among the other biomarkers, the excretion of uKIM-1 on day zero of KRT had a superior performance as a CRR predictor [(AUC, 0.71 (p = 0.017)], and as a mortality predictor [AUC, 0.68 (p = 0.028)]. In the metabolomics analysis, we identified four distinct profiles; the metabolite that maintained statistical significance in predicting mortality was p-cresol glucuronide. Conclusions: This study strongly suggests that uSerpinA3 and uKIM-1 can predict CRR and mortality in patients with critical COVID-19 and AKI requiring KRT. Metabolic analysis appears promising for identifying affected pathways and their clinical impact in this population.

31 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
IZImelda Cecilia Zarzoza-Mendoza
Imelda Cecilia Zarzoza-Mendoza
MRMaricela Rodríguez-Cruz
Maricela Rodríguez-Cruz
MCM. Cristina Carmona-Isunza
M. Cristina Carmona-Isunza
HSHilda Sánchez-Vidal
Hilda Sánchez-Vidal
JFJosé Carlos Páez Franco
José Carlos Páez Franco
LBLourdes Barbosa-Cortés
Lourdes Barbosa-Cortés
Background/Objective: Human milk is an irreplaceable source of nutrition and is essential for the infant’s growth and development right after birth and for early life stage survival. This study aims to characterize and compare the metabolite profiles of colostrum and transitional and mature milk using an untargeted GC-MS approach. Additionally, it explores potential correlations between the identified metabolites and maternal nutritional factors. Methods: This was a longitudinal, prospective, and observational study. We included human milk samples from 113 Mexican women who practiced exclusive breastfeeding. Partial least squares-discriminant analysis (PLS-DA) was performed to assess differences among lactation stages. Metabolites showing significant variation across lactation stages were further analyzed using Friedman tests with post hoc Wilcoxon tests and Bonferroni correction. Correlations with maternal anthropometric measures were evaluated. Results: Twenty-three metabolites were identified, including amino acids and derivatives, sugars, fatty acids, and energetic metabolites. Alanine and creatinine levels decreased during lactation, while aspartate, serine, and valine levels increased. Rhamnose level was higher in colostrum, whereas decanoic, dodecanoic, and tetradecanoic acid levels increased over time, and that of 11,14-eicosadienoic acid decreased. Lactic acid levels declined across stages. Negative correlations were found between several amino acids and maternal anthropometric variables, while glyceric acid, rhamnose and lactic acid correlated positively. Conclusions: Human milk metabolomic profiles display distinct, stage-specific variations shaped by maternal characteristics, reflecting the dynamic physiological and nutritional demands of the developing infant

9 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
IZImelda Cecilia Zarzoza-Mendoza
Imelda Cecilia Zarzoza-Mendoza
MRMaricela Rodríguez-Cruz
Maricela Rodríguez-Cruz
MCM. Cristina Carmona-Isunza
M. Cristina Carmona-Isunza
HSHilda Sánchez-Vidal
Hilda Sánchez-Vidal
JFJosé Carlos Páez Franco
José Carlos Páez Franco
LBLourdes Barbosa-Cortés
Lourdes Barbosa-Cortés
Background/Objective: Human milk is an irreplaceable source of nutrition, is essential for the infant’s growth and development right after birth and for early life stages survival. This study aims to characterize and compare the metabolite profiles of colostrum, transitional, and mature milk using an untargeted GC-MS approach. Additionally, it explores potential correlations between the identified metabolites and maternal nutritional factors. Methods: This was a longitudinal, prospective, and observational study. We included human milk samples from 113 Mexican women who practiced exclusive breastfeeding. Partial least squares-discriminant analysis (PLS-DA) was performed to assess differences among milk types. Metabolites showing significant variation across lactation stages were further analyzed using Friedman tests with post hoc Wilcoxon tests and Bonferroni correction. Correlations with maternal anthropometric were evaluated. Results: Twenty-three metabolites were identified, including amino acids and derivatives, sugars, fatty acids, and energetic metabolites. Alanine and creatinine decreased during lactation, while aspartate, serine, and valine increased. Rhamnose was higher in colostrum, whereas decanoic, dodecanoic, and tetradecanoic acids increased over time, and 11,14-eicosadienoic acid decreased. Lactic acid declined across stages. Positive correlations were found between several amino acids and maternal anthropometric variables, while lactic acid correlated negatively. Conclusions: Human milk metabolomic profiles display distinct, stage-specific variations shaped by maternal characteristics, reflecting the dynamic physiological and nutritional demands of the developing infant.